Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2003
07/24/2003US20030139334 Cell cycle controlling protein; vaccines
07/24/2003US20030139330 Transcription factors containing two potential dna binding motifs
07/24/2003US20030139329 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030139328 Complexing; modulating biological activation
07/24/2003US20030139327 Nucleic acids, proteins, and antibodies
07/24/2003US20030138972 Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications
07/24/2003US20030138955 Delivering nucleotide sequences coding myogenin protein for improving angiogenesis and/or neovascularisation; skin grafting; tissue engineering; wound healing agents; gene therapy
07/24/2003US20030138954 Self-inactivating plasmid/vector; gene therapy; treating hematological disorders; anticarcinogenic agents
07/24/2003US20030138951 Conversion of liver stem and progenitor cells to pancreatic functional cells
07/24/2003US20030138950 Cultured genetically engineered biocompatible living stents; artifical prosthetic grafts; anticoagulants; antirestenosis; side effect reduction
07/24/2003US20030138949 Methods for the regeneration of pancreatic islets and expansion of pancreatic endocrine cells
07/24/2003US20030138948 Pluripotent pancreatic tissue for generating differentiated islets of langerhans; drug screening; regeneration medicine; antidiabetic agents
07/24/2003US20030138947 Using cyclophosphoamide to retrodifferentiate hemopioetic cells into pluripotent stem cells and redifferentiate them into myleoid cells; treating immunological disorders; anticarcinogenic agents
07/24/2003US20030138946 Genetically engineered major histocompatibiity complex antigen presenting cells for activating CD8 lymphocytes and producing cytokines and becoming cytotoxic; antitumor agents
07/24/2003US20030138945 Tissue control rods for sheet-based tissue engineering
07/24/2003US20030138944 Method of transducing a protein into cells
07/24/2003US20030138931 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents
07/24/2003US20030138927 Nucleic acid molecules encoding enzymes having fructosyl polymerase activity
07/24/2003US20030138926 Novel polynucleotides and polypeptides encoded thereby
07/24/2003US20030138923 Targeted system for removing tumor cells from cell populations
07/24/2003US20030138921 Recombinantly producing levodione reductase
07/24/2003US20030138914 Factor X deletion mutants and analogues thereof
07/24/2003US20030138911 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
07/24/2003US20030138904 Pro-polypeptide membrane protein for stimulating/inhibiting proliferation/differentiation of chrondrocytes and/or endothelial cells; neovascularization; tumor diagnosis
07/24/2003US20030138903 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138902 Pro-polypeptide membrane protein for stimulating/inhibiting proliferation/differentiation of chrondrocytes and/or endothelial cells; neovascularization; tumor diagnosis
07/24/2003US20030138901 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138900 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138898 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138897 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138893 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138892 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138891 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138889 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138888 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138887 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
07/24/2003US20030138886 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138885 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138884 APRIL- a novel protein with growth effects
07/24/2003US20030138883 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
07/24/2003US20030138882 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/24/2003US20030138854 Method for determining BAGE expression
07/24/2003US20030138839 Polypeptide comprising ubiquitination regulating domain; antiproliferative agents; neuroprotectants; cancer diagnosis
07/24/2003US20030138836 Detecting modulators of a silencing mediator for retinoic acid receptor; relieving suppression of steroid/thyroid hormone receptor activity; GAL4 DNA binding domains
07/24/2003US20030138833 Psoriasin expression by breast epithelial cells
07/24/2003US20030138832 Modulating insulin receptor signaling through targeting FACL
07/24/2003US20030138822 Polynucleotides and polypeptides, materials incorporating them and methods for using them
07/24/2003US20030138820 Sugar transport protein for use in diagnosis and treatment of diabetes, hypertriglyceridemia and hyperinsulinemia
07/24/2003US20030138818 G-protein coupled receptors
07/24/2003US20030138815 Cyclic adenosine monophosphate (cAMP); drug screening; bronchodilators; antiinflammatory agents; immunomodulators; antiallergens; bioassays
07/24/2003US20030138807 Nucleotide sequences coding polypeptide associated with biosynthesis of glycans found as free oligosaccharides or bound to glycosphingolipids; treatment and prevention of infections; gene therapy; antiproliferative agents
07/24/2003US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy
07/24/2003US20030138769 Immunogenic HBc chimer particles having enhanced stability
07/24/2003US20030138453 Microparticles comprise a polymer such as a poly(alpha-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, a polyorthoester, a polyanhydride, formed using cationic, anionic, or nomonic detergents; drug delivery
07/24/2003US20030138444 Composition and method for treating HIV infection
07/24/2003US20030138441 A polynucleotide sequence which encodes a Dermatophagoides dust mite protein, wherein the codon usage pattern of the polynucleotide sequence resembles that of highly expressed mammalian genes
07/24/2003US20030138440 Multimeric proteins and methods of making and using same
07/24/2003US20030138435 Gene encoding Cu/Zn superoxide dismutase, and cytotrophoblast express, after 3 days of culture, a peptide hormone selected from human placental lactogen, alpha or beta human chorionic gonadotrophin, human placental growth hormone and leptin
07/24/2003US20030138433 Contacting isolated B-cell in vitro with a target antigen conjugate to produce target antigen manipulated B cells, fusing manipulated cells into the subject
07/24/2003US20030138425 An antibody that preferentially binds to the same epitope on cytokeratin 8 as antibody mhoe-4 preferentially binds; linked to a therapeutic agent,e.g., saporin; kits; antiproliferation agents; immunotherapy; diagnosis/medical
07/24/2003US20030138422 Antibodies against growth and differentiation factor-8 (GDF-8), also known as myostatin, including fragments; muscle and bone degenerative disorders; muscular dystropy/atrophy; antidiabetic agents; congestive obstructive pulmonary disease
07/24/2003US20030138421 Human Antibodies specific for interleukin 15 (IL-15)
07/24/2003US20030138413 Activating dendritic cells from the host which are rendered hyporesponsive to activation stimuli by the disease by administering a tumor-derived DC inhibitory factor antagonist in combination with a Toll-like receptor agonist
07/24/2003US20030138411 Gene expression in monocytes and macrophages
07/24/2003US20030138410 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
07/24/2003US20030138409 Th1 specific cd4 t cell lines and method for inducing them ex vivo
07/24/2003CA2841097A1 Albumin fusion proteins
07/24/2003CA2680946A1 Pim-3 kinase as a target for type 2 diabetes mellitus
07/24/2003CA2477348A1 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
07/24/2003CA2474141A1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
07/24/2003CA2473434A1 Methods for making polynucleotides and purifying double-stranded polynucleotides
07/24/2003CA2473115A1 Remedy for dysmnesia
07/24/2003CA2473108A1 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
07/24/2003CA2473039A1 Novel anti-igf-ir antibodies and uses thereof
07/24/2003CA2472759A1 Gb virus b based replicons and replicon enhanced cells
07/24/2003CA2472016A1 Method and device for identifying substances capable of modulating adipicyte differentiation
07/24/2003CA2471907A1 Antibody-avidin fusion proteins as cytotoxic drugs
07/24/2003CA2471891A1 Methods of inducing or enhancing connective tissue repair
07/24/2003CA2471702A1 Human monoclonal antibodies against cd30
07/24/2003CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
07/24/2003CA2471363A1 Albumin fusion proteins
07/24/2003CA2470527A1 Methods and compositions for generating a genetically modified animal using lentiviral vectors
07/24/2003CA2470421A1 Use of a novel cell surface protease from group b streptococcus
07/24/2003CA2470400A1 Cultured and encapsulated pancreatic stem cells
07/24/2003CA2470359A1 Assay for the detection of factors that modulate the expression of ingap
07/24/2003CA2469800A1 Methods for the induction of professional and cytokine-producing regulatory cells
07/24/2003CA2469715A1 Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
07/24/2003CA2469472A1 Endothelial stem cells, populations, methods of isolation and use thereof
07/24/2003CA2465178A1 Adapter-directed display system
07/24/2003CA2463008A1 Efficient protein expression system
07/24/2003CA2438106A1 Rapid method of selecting cells for gene disruption by homologous recombination
07/23/2003EP1329509A2 Method for generating a subtracted cDNA library and uses of the generated library
07/23/2003EP1329507A1 Artificial protein having potentiated immunogenicity of epitope
07/23/2003EP1329500A1 An anthocyanin producing callus line of Panax sikkimensis and a method for producing the same
07/23/2003EP1329499A2 Growth factor-responsive progenitor cells which can be proliferated in vitro
07/23/2003EP1329459A2 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
07/23/2003EP1329223A1 Expression potentiator for protein synthesis regulatory gene
07/23/2003EP1328816A2 Regulation of neutral development by daedalos
07/23/2003EP1328661A2 Estrogen receptor alpha variants and methods of detection thereof
07/23/2003EP1328651A2 Monocotyledon plant cells and plants which synthesise modified starch
1 ... 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 ... 1827